These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10983783)

  • 21. Practitioner versus medication-expert opinion on psychiatric pharmacotherapy of mentally retarded patients with mental disorders.
    Patel NC; Crismon ML; Rush AJ; Frances A
    Am J Health Syst Pharm; 2001 Oct; 58(19):1824-9. PubMed ID: 11596698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tranquilizer reduction trials in a residential program for persons with mental retardation.
    Spreat S; Serafin C; Behar D; Leiman S
    Hosp Community Psychiatry; 1993 Nov; 44(11):1100-2. PubMed ID: 7904579
    [No Abstract]   [Full Text] [Related]  

  • 23. For what diagnoses are psychotropic medications being prescribed?: a nationally representative survey of physicians.
    Mark TL
    CNS Drugs; 2010 Apr; 24(4):319-26. PubMed ID: 20297856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brief report: reliability and validity of instruments for assessing psychotropic medication effects on self-injurious behavior in mental retardation.
    Schroeder SR; Rojahn J; Reese RM
    J Autism Dev Disord; 1997 Feb; 27(1):89-102. PubMed ID: 9018584
    [No Abstract]   [Full Text] [Related]  

  • 25. Yonder: Self-harm, repeat prescribing, deprescribing, and worry.
    Rashid A
    Br J Gen Pract; 2016 May; 66(646):261. PubMed ID: 27127282
    [No Abstract]   [Full Text] [Related]  

  • 26. Psychopharmacotherapy in children and adults with intellectual disability.
    Santosh PJ; Baird G
    Lancet; 1999 Jul; 354(9174):233-42. PubMed ID: 10421318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of Psychotropic Polypharmacy Among Outpatients With Psychiatric Disorders and Intellectual Disability.
    Lunsky Y; Modi M
    Psychiatr Serv; 2018 Feb; 69(2):242-246. PubMed ID: 29089006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nature and quality of antipsychotic prescribing practice in UK psychiatry of intellectual disability services.
    Paton C; Flynn A; Shingleton-Smith A; McIntyre S; Bhaumik S; Rasmussen J; Hardy S; Barnes T
    J Intellect Disabil Res; 2011 Jul; 55(7):665-74. PubMed ID: 21507097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug-refractory aggression, self-injurious behavior, and severe tantrums in autism spectrum disorders: a chart review study.
    Adler BA; Wink LK; Early M; Shaffer R; Minshawi N; McDougle CJ; Erickson CA
    Autism; 2015 Jan; 19(1):102-6. PubMed ID: 24571823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quality of prescribing of antipsychotic medication for people with intellectual disability under the care of UK mental health services: a cross-sectional audit of clinical practice.
    Paton C; Bhatti S; Purandare K; Roy A; Barnes T
    BMJ Open; 2016 Dec; 6(12):e013116. PubMed ID: 27920085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reporting of medication regimen in applied studies of persons with mental retardation and ADHD.
    Christian L; Kerr CL; Sutphin GE; Poling A
    Res Dev Disabil; 1997; 18(5):319-27. PubMed ID: 9292927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of divalproex sodium on aggression and self-injurious behaviour in adults with intellectual disability: a retrospective review.
    Ruedrich S; Swales TP; Fossaceca C; Toliver J; Rutkowski A
    J Intellect Disabil Res; 1999 Apr; 43 ( Pt 2)():105-11. PubMed ID: 10221790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychotropic medications prescribing patterns for children and adolescents in New York's public mental health system.
    Lyons JS; MacIntyre JC; Lee ME; Carpinello S; Zuber MP; Fazio ML
    Community Ment Health J; 2004 Apr; 40(2):101-18. PubMed ID: 15206636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Annotation: The use of psychotropic medications in children: a British view.
    Bramble D
    J Child Psychol Psychiatry; 2003 Feb; 44(2):169-79. PubMed ID: 12587854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Challenging behavior in adults with epilepsy and intellectual disability: An analysis of epilepsy characteristics.
    van Ool JS; Snoeijen-Schouwenaars FM; Tan IY; Jurgen Schelhaas H; Aldenkamp AP; Hendriksen JGM
    Epilepsy Behav; 2018 Sep; 86():72-78. PubMed ID: 30153936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study.
    Sheehan R; Hassiotis A; Walters K; Osborn D; Strydom A; Horsfall L
    BMJ; 2015 Sep; 351():h4326. PubMed ID: 26330451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychiatric disorders in children and adolescents with mental retardation and developmental disabilities.
    Des Noyers Hurley A
    Curr Opin Pediatr; 1996 Aug; 8(4):361-5. PubMed ID: 8954267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Behavioral disorders and substance abuse in adolescents with mental retardation].
    Papachristou E; Anagnostopoulos D
    Psychiatriki; 2014; 25(2):139-50. PubMed ID: 25035183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Psychotropic drug prescription to people with intellectual disability in GP practices].
    Bakker-van Gijssel EJ; Leusink GL
    Ned Tijdschr Geneeskd; 2015; 159():A9754. PubMed ID: 26629605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Possibilities and limits of treatment of aggressive behavior in patients with mental retardation with risperidone].
    Hässler F; Buchmann J; Bohne S
    Nervenarzt; 2002 Mar; 73(3):278-82. PubMed ID: 11963264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.